Breaking News
Get 50% Off 0
📈 Q2 Earnings Alert! Critical earnings dates you can't miss
See Calendar
Close

Nippon India Pharma Fund - Direct Plan - Bonus Plan (0P0000XVFI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
584.436 +0.694    +0.12%
16/07 - Closed. Currency in INR
Type:  Fund
Market:  India
ISIN:  INF204K01I27 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 85.69B
Reliance Pharma Fund - Direct Plan - Bonus Plan 584.436 +0.694 +0.12%

0P0000XVFI Technical Analysis

 
A brief summary - strong Buy, Buy, strong sell, sell or neutral signals for the Nippon India Pharma Fund - Direct Plan - Bonus Plan fund. Access detailed technical analysis through moving averages buy/sell signals (simple and exponential for 5,10,20,50,100 and 200 periods) and common chart indicators (RSI, Stochastics, StochRSI, MACD, ADX, CCI, ROC, Williams %R, Ultimate and more) Buy, Sell, Overbought, Oversold or Neutral signals. Also - pivot points levels for Standard, Fibonacci, Camarilla, Woodie's and Demark's are supplied. All 0P0000XVFI fund Technical Studies are available in different time frames.
Summary:Strong Buy
Moving Averages:Strong BuyBuy (12)Sell (0)
Technical Indicators:Strong BuyBuy (7)Sell (0)

Pivot PointsJul 16, 2025 22:11 GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 573.867 575.842 579.792 581.767 585.717 587.692 591.642
Fibonacci 575.842 578.105 579.504 581.767 584.030 585.429 587.692
Camarilla 582.112 582.655 583.199 581.767 584.285 584.828 585.371
Woodie's 574.853 576.335 580.778 582.260 586.703 588.185 592.628
DeMark's - - 580.779 582.260 586.704 - -

Technical IndicatorsJul 16, 2025 22:11 GMT

Name Value Action
RSI(14) 65.396 Buy
STOCH(9,6) 49.418 Neutral
STOCHRSI(14) 76.503 Overbought
MACD(12,26) 4.570 Buy
ADX(14) 41.337 Buy
Williams %R 0.000 Overbought
CCI(14) 208.4847 Overbought
ATR(14) 2.7343 Less Volatility
Highs/Lows(14) 5.1921 Buy
Ultimate Oscillator 60.701 Buy
ROC 2.455 Buy
Bull/Bear Power(13) 13.6398 Buy

Buy: 7

Sell: 0

Neutral: 1


Summary:Strong Buy

Moving AveragesJul 16, 2025 22:11 GMT

Period Simple Exponential
MA5 578.774
Buy
581.115
Buy
MA10 579.124
Buy
578.447
Buy
MA20 574.281
Buy
575.541
Buy
MA50 565.171
Buy
565.229
Buy
MA100 547.994
Buy
559.404
Buy
MA200 554.948
Buy
545.890
Buy

Buy: 12

Sell: 0


Summary:Strong Buy

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XVFI Comments

Write your thoughts about Nippon India Pharma Fund - Direct Plan - Bonus Plan
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email